Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury
Launched by SHEPHERD CENTER, ATLANTA GA · Jan 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of noninvasive spinal stimulation can help people with spinal cord injuries. Specifically, the study aims to see if this stimulation can reduce involuntary muscle movements (known as spasticity), improve muscle strength, and lessen pain. Participants will receive electrical stimulation through electrodes placed on their lower back and stomach. The study will take place at the Shepherd Center and will require participants to visit for 2-3 hours a day, four days a week, for 2-3 weeks.
To join the study, participants need to be at least 16 years old and have experienced a spinal cord injury at least three months prior. They should also have some level of spasticity in their legs and be able to follow instructions and communicate any discomfort. However, certain individuals, such as those with worsening spinal issues, certain heart conditions, or who are pregnant, may not be eligible. Overall, this trial offers a chance to explore new ways to help manage symptoms related to spinal cord injuries in a supportive environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must agree to allow use of health information.
- • Participants should be 16 years old or older.
- • Participants must have had a spinal cord injury (SCI) of any severity (AIS A, B, C, or D) that happened at least 3 months ago.
- • Objectively measurable spasticity in your legs.
- • Participants must inform the investigators if there is a change in medications during the study.
- • Participants must be able to follow instructions.
- • Participants must be able to communicate if pain or discomfort is experienced.
- Exclusion Criteria:
- • People with spinal issues that are getting worse, such as degenerative or progressive vascular disorders.
- • People neurological problems other than SCI.
- • People with an injury level is below T12.
- • People with heart issues, such as atrial fibrillation.
- • People with bone or joint problems that would make it hard to follow the study plan.
- • Women who are pregnant.
- • People with implanted stimulators (like a baclofen pump, spinal stimulator, heart defibrillator, or diaphragmatic pacemaker)
- • People with infection.
- • People with skin that is broken.
- • People who have or had certain types of cancer.
- • People who have had long-lasting spasticity treatment (like botox or selective dorsal rhizotomy).
About Shepherd Center, Atlanta Ga
Shepherd Center, located in Atlanta, Georgia, is a nationally recognized non-profit hospital specializing in the rehabilitation of individuals with spinal cord injury, brain injury, and other neuromuscular conditions. Committed to advancing medical knowledge and improving patient outcomes, Shepherd Center conducts innovative clinical trials that explore new treatment modalities and rehabilitation strategies. The center’s multidisciplinary team of experts collaborates with leading researchers and institutions to ensure the highest standards of care and research integrity, fostering an environment that prioritizes patient safety and ethical considerations in all clinical endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Edelle C Field-Fote, PT, PhD
Principal Investigator
Shepherd Center, Atlanta GA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported